Rare diseases
Investigational molecules
Locations
Phase II Study of BI 764532 Added to Platinum Chemotherapy in Adults with Advanced Large‑Cell Neuroendocrine Lung Cancer
GermanyEpcoritamab plus rituximab versus rituximab alone in elderly, frail or unfit patients with newly diagnosed diffuse large B‑cell lymphoma
BelgiumSafety and Efficacy of Intrathecal BIIB115 in Infants with Spinal Muscular Atrophy Previously Treated with Onasemnogene Abeparvovec
BelgiumPerioperative Zanidatamab and Tislelizumab with Chemotherapy for Patients with HER2‑Positive Locally Advanced Operable Gastroesophageal Adenocarcinoma
BelgiumTargeted peri‑operative prophylaxis using eravacycline (drug combination) versus standard prophylaxis in liver transplant patients colonized with CPE
ItalyPostoperative Delirium Incidence and Severity in Patients ≥75 Years Undergoing Femur Osteosynthesis Sedated with Dexmedetomidine vs Propofol
SpainEfficacy and Safety of Amara‑Tropfen Dilution vs Placebo in Patients with Irritable Bowel Syndrome
GermanyEvaluation of 68Ga-FAPI-46 and Fluor-18-FDG PET/MRI in Paediatric Sarcoma Patients
DenmarkOral bioavailability and tolerability of hydrocortisone tablets vs hydrocortisone sodium phosphate orodispersible films in children and adolescents with adrenal insufficiency
GermanyPrehospital Sedation with Esketamine versus Propofol in Patients with Severe Acute Brain Injury
DenmarkEfficacy and Safety of Lucerastat in Treatment‑Naïve Adult Male Patients with Fabry Disease
FranceSafety and tolerability study of S-241656 with posaconazole in patients with AML, MDS/AML or CMML
FinlandTell us about your condition – we search every trial in Europe and connect you with the right site.
